Stable Expression of the Sodium/Iodide Symporter (NIS) for anti-Cancer Gene Therapy of Glioma Cells Using a Third Generation Self-Inactivating Lentiviral Vector System in Combination with 211At

Publisher： Bentham Science Publishers

E-ISSN： 1874-4729|3|4|322-333

ISSN： 1874-4710

Source： Current Radiopharmaceuticals, Vol.3, Iss.4, 2010-10, pp. : 322-333

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Sodium-Iodide Symporter

By  

Current Drug Targets - Immune, Endocrine & Metabolic Disorders, Vol. 4, Iss. 3, 2004-09 ,pp. : 167-174

Bentham Science Publishers

Access to resources Recommend Favorite

The Sodium Iodide Symporter (NIS) as an Imaging Reporter for Gene, Viral, and Cell-based Therapies

By  

Current Gene Therapy, Vol. 12, Iss. 1, 2012-01 ,pp. : 33-47

Bentham Science Publishers

Access to resources Recommend Favorite

A Transporter Gene (Sodium Iodide Symporter) for Dual Purposes in Gene Therapy: Imaging and Therapy

By  

Current Gene Therapy, Vol. 2, Iss. 4, 2002-12 ,pp. : 393-402

Bentham Science Publishers

Access to resources Recommend Favorite

The Biology of the Sodium Iodide Symporter and its Potential for Targeted Gene Delivery

By  

Current Cancer Drug Targets, Vol. 10, Iss. 2, 2010-03 ,pp. : 242-267

Bentham Science Publishers

Access to resources Recommend Favorite

Gene Therapy Using an Adenovirus Vector for Apoptosis-Related Genes is a Highly Effective Therapeutic Modality for Killing Glioma Cells

By  

Current Gene Therapy, Vol. 3, Iss. 2, 2003-04 ,pp. : 147-153

Bentham Science Publishers

Access to resources Recommend Favorite